Purchases and Sales Made in Q4 2023 in Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX) during Q4 2023. The information is specifically focused on institutions that hold shares of Syndax Pharmaceuticals Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-92.5K- 79.13% |
$1.05M - $2M
|
24.4K
$322K
|
|
|
Feb 14, 2024
Q4 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-100K- 10.0% |
$1.14M - $2.17M
|
900K
$11.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Twinbeech Capital LP
Purchase, NY |
SELL
|
- |
-105K- 55.63% |
$1.19M - $2.27M
|
83.5K
$1.1M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-107K- 71.75% |
$1.21M - $2.31M
|
42K
$553K
|
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-149K- 72.21% |
$1.7M - $3.23M
|
57.4K
$756K
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-166K- 39.37% |
$1.89M - $3.6M
|
256K
$3.37M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-193K- 44.2% |
$2.19M - $4.17M
|
243K
$3.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Saturn V Capital Management LLC
Austin, TX |
SELL
|
- |
-289K- 35.79% |
$3.29M - $6.27M
|
519K
$6.84M
|
|
|
Feb 12, 2024
Q4 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-507K- 32.01% |
$5.77M - $11M
|
1.08M
$14.2M
|
|
|
Aug 15, 2024
Q4 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-1.08M- 50.05% |
$12.3M - $23.4M
|
1.08M
$14.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-2.12M- 78.07% |
$24.1M - $45.9M
|
596K
$7.85M
|
|
|
Feb 01, 2024
Q4 2023
|
Jennison Associates LLC
|
SELL
|
- |
-2.3M- 97.84% |
$26.2M - $49.8M
|
50.8K
$669K
|